Julian Burke appointed chair of Camena Bioscience’s board

30 March 2021

Leading life science executive Julian Burke joins Camena's board.

Read more

Chesterford Research Park expansion

22 February 2021

We're expanding to build a high throughput DNA synthesis facility at Chesterford Research Park.

Read More


Enzymatic DNA synthesis enters new phase

5 October 2020

Camena Bioscience's breakthrough enzymatic DNA synthesis technology featured in Nature Biotechnology.

Read More

Camena Bioscience uses gSynth™ to synthesise a 2.7kb plasmid

5th February 2020

Synthetic biology company, Camena Bioscience, announces the achievement of another significant DNA synthesis technology milestone. Using gSynth, a novel multi-enzymatic de novo DNA synthesis and gene assembly technology, Camena Bioscience has produced a whole plasmid of 2.7kb.

Read More

Camena Bioscience’s breakthrough in the accuracy of synthetic DNA production

  • 23 October 2019

Synthetic biology company, Camena Bioscience, announces a significant breakthrough in DNA synthesis accuracy with the development of an innovative technology called gSynth™. With this pioneering enzymatic de novo synthesis and gene assembly method, gSynth is able to produce 300 nucleotide DNA molecules with an accuracy as high as 90%.

Read More


Find out more about gSynthTM and how it can enable new synthetic biology applications

See the infographic

Synthetic biology is changing the world

  • 4 March 2019

Camena Bioscience CEO, Steve Harvey, discusses synthetic biology tools and the importance of being able to produce synthetic DNA and RNA molecules.

Read More